Ionic Pharmaceuticals leverages polymer chemistry and biomedical engineering to develop innovative solutions to clinical challenges. Our strategies exploit the fundamental pathophysiology underlying a disease state to guide the development of our therapies.

​

As a spin-out of Boston University, we aim to improve the outcomes and quality-of-life for patients through the development and commercialization of new biomaterials, devices and drug-delivery systems.

​